NCT02434718 - Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 24, 2015

Primary Completion Date

December 9, 2016

Study Completion Date

December 9, 2016

Conditions

Alzheimer's Disease

Interventions

DRUG

Aducanumab

As described in the treatment arm

DRUG

Placebo

IV administration of 0.9% sodium chloride

Trial Locations (7)

Research Site, Tōon

Research Site, Kobe

Research Site, Kamakura

Research Site, Kanzaki

Research Site, Kodaira

Research Site, Shinjuku

Research Site, Kyoto